Ixekizumab proves highly effective for palmoplantar, scalp psoriasisDecember 21, 2016PsoriasisPsoriatic Arthritis
Pediatric psoriasis linked to multiple psychiatric comorbiditiesNovember 21, 2016PsoriasisPsoriatic Arthritis
Infliximab biosimilar posts mostly reassuring data in Norway’s NOR-SWITCH studyNovember 20, 2016Psoriatic ArthritisPsoriasis
VIDEO: Consider comorbidities when preparing patients for systemic psoriasis therapyNovember 11, 2016PsoriasisPsoriatic Arthritis
Study offers reassuring data on certolizumab use in pregnancyNovember 10, 2016PsoriasisPsoriatic Arthritis
Close monitoring of psoriasis patients can delay PsA onsetNovember 2, 2016PsoriasisPsoriatic Arthritis
PsA bone loss measurement: A surrogate for radiographic progression?November 1, 2016Psoriatic ArthritisPsoriasis
Tildrakizumab for psoriasis scores high marks in phase IIIOctober 19, 2016PsoriasisPsoriatic Arthritis
Secukinumab for psoriasis at 4 years: undiminished efficacy and safetyOctober 18, 2016PsoriasisPsoriatic Arthritis
Guselkumab achieves highest-ever response rates in psoriasisOctober 12, 2016PsoriasisPsoriatic Arthritis
